Scinovex
review Open AccessTop 1% cited

Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease

Nutrients · 2013 · Vol. 5(5) · pp. 1544–1560
Melania GagginiMariangela MorelliE. BuzzigoliRalph A. DeFronzoElisabetta BugianesiAmalia Gastaldelli

Abstract

Non-alcoholic fatty liver disease is marked by hepatic fat accumulation not due to alcohol abuse. Several studies have demonstrated that NAFLD is associated with insulin resistance leading to a resistance in the antilipolytic effect of insulin in the adipose tissue with an increase of free fatty acids (FFAs). The increase of FFAs induces mitochondrial dysfunction and development of lipotoxicity. Moreover, in subjects with NAFLD, ectopic fat also accumulates as cardiac and pancreatic fat. In this review we analyzed the mechanisms that relate NAFLD with metabolic syndrome and dyslipidemia and its association with the development and progression of cardiovascular disease.

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseAlcohol Consumption and Health EffectsInsulin resistanceInternal medicineLipotoxicityFatty liverDyslipidemiaMetabolic syndromeEndocrinologyMedicineAdipose tissueSteatosis

MeSH terms

Adipose TissueCoronary Artery DiseaseFatty Acids, NonesterifiedFatty LiverHumansInsulinInsulin ResistanceLiverMitochondriaMyocardiumPancreasMetabolic SyndromeDyslipidemiasAtherosclerosisNon-alcoholic Fatty Liver Disease

Funding

  • European Foundation for the Study of Diabetes
Citations
816
FWCI
34.60
field-weighted impact
References
96
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.